Preclinical studies showed that PARP1 can interact with ERG, and inhibition of PARP1 enhanced DNA double-strand breaks induced by ERG overexpression and slowed the growth of ERG-positive prostate cancer cells [35]. Here, PARP1 is linked to Familial prostate cancer.